Ishares Nasdaq Biotechnology ETF (IBB)
$139.21 1.36 (0.97%)
19:58 EDT IBB Stock Quote Delayed 30 Minutes
Previous Close $139.21
Market Cap 12.10B
PE Ratio -
Volume (Avg. Vol.) 2.91M
Day's Range 138.62 - 140.87
52-Week Range 92.15 - 142.33
Dividend & Yield 0.31 (0.22%)
IBB Stock Predictions, Articles, and Ishares Nasdaq Biotechnology ETF News
- From InvestorPlace
- From the Web
You should buy the dip in life science stocks because their long-term futures are assured. Here are seven to pick up today.
Major Biotech companies report mixed Q3 results.
After a long stint of selling, AGN stock is finally showing signs of stabilization. I want to generate income from Allergan support.
Pfizer has been a boring stock for years. Which makes PFE stock perfect to sell downside risk against unlikely scenarios.
Biotech falling knives like Amgen are notoriously dangerous, but AMGN stock has value against which I am willing to bet bullish.
This latest pullback in AMGN stock now looks to provide a better reward-to-risk opportunity to buy Amgen again.
Pharma stock falling knives are the scariest to catch. But this reaction to the Celgene headline is overdone. Catch CELG but with caution.
Momentum rallies are often a show of good support. Bet on Pfizer (PFE ) stock's proven levels to hold for at least six months.
These biotech stocks are making a comeback amid several positive catalysts for the sector and markets as a whole.
For a while GILD stock was a hideous knife to catch. But now that it reestablished its bottom, I can safely make money in Gilead.
AMGN stock is higher by just about 27% for the year-to-date, but in the bigger picture Amgen really just started on a new breakout rally.
Pharma stocks like Allergan scare most investors out of trading them when they fall. Sell AGN puts with a big buffer for easy profits.
Momentum stocks especially in the biotech industry are daunting knives to catch. Make it easier by selling puts for income with a big buffer.
BMY is rallying on solid fundamentals to reclaim a long-term pivot levels as support for even higher prices. Go long on strong support.
Wall Street goes on buying sprees into the biotech sector. Take advantage of this run to profit from red hot AMGN Stock. It's headed higher.
The biotech trade is always a momentum bet, and currently Wall Street is betting it will go up. I can use this play in XBI for free income.
Volatility remains eerily low, but as a former mentor used to remind me, one can learn much by just watching and being prepared.
The sound technical backdrop not only in biotech such as the IBB ETF but also in healthcare continues to favor the bulls for the time being.